SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽Demo🎬Demo VideoℹVision

What molecular mechanisms enable functional recovery and muscle re-innervation after motor neuron loss in ALS/FTLD?

PARTIALLY ADDRESSED

The study shows dramatic functional recovery and muscle re-innervation after cytoplasmic TDP-43 clearance, even following motor neuron death. The cellular and molecular mechanisms underlying this unexpected regenerative capacity in neurodegenerative disease are not explained. Gap type: unexplained_observation Source paper: Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. (2015, Acta neuropathologica, PMID:26197969)

Priority: 0.89 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What molecular mechanisms enable functional recovery and muscle re-innervation after motor neuron loss in ALS/FTLD? is a 0.89 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What molecular mechanisms enable functional recovery and muscle re-innervation after motor neuron loss in ALS/FTLD? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (9)

ALS→NEURONALS→NEURODEGENERATIONALS→DEMENTIAALS→Amyotrophic Lateral SclerosisALS→GENES
▸ Show 4 more

associated with (23)

entities-hepcidin→ALSentities-ros→ALSentities-atp7b-gene→ALSentities-reactive-oxygen-species→ALSentities-astrocytes→ALS
▸ Show 18 more

biomarker for (1)

ALS→Amyotrophic Lateral Sclerosis

causes (5)

ALS→DEMENTIAALS→Amyotrophic Lateral SclerosisALS→DementiaALS→AMYOTROPHIC LATERAL SCLEROSISSOD1→ALS

inhibits (1)

ALS→Als

interacts with (3)

ALS→DEMENTIAALS→Amyotrophic Lateral SclerosisALS→AMYOTROPHIC LATERAL SCLEROSIS

regulates (3)

ALS→Amyotrophic Lateral SclerosisALS→AlsALS→AMYOTROPHIC LATERAL SCLEROSIS

therapeutic target (5)

ALS→NeurodegenerationALS→Amyotrophic Lateral SclerosisALS→AgingNEURODEGENERATIVE DISEASES→ALSALS→Als
🕑 Activity Feed
✏ update on knowledge_gap by max_outlook1 2026-04-28T01:37
✏ update on knowledge_gap by None 2026-04-25T22:15
✏ update on knowledge_gap by None 2026-04-14T14:01
✏ update on knowledge_gap by None 2026-04-14T14:01
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps